NBY - NovaBay Pharmaceuticals Stock Is Up 50%: What's Going On? | Benzinga
NovaBay Pharmaceuticals Inc (NASDAQ:NBY) shares are trading higher by 50% to $0.18 Monday, despite a lack of company-specific news for the session. The company last week announced it launched new Avenova product bundles aimed at providing tailored, cost-effective relief for dry eye symptoms.
The company says these bundles reflect the multifaceted nature of dry eye disease and align with recommendations from the 2024 Eyes on Eyecare Dry Eye Report, which highlights the importance of personalized treatment strategies beyond artificial tears.
Justin Hall, CEO of NovaBay, noted the rising prevalence of dry eye syndrome in the U.S., affecting around 16 million people, and the expected growth of the U.S. dry eye treatment market from $3.02 billion in 2023 to $4.86 ...